# OnCo record chemotherapy-dosing-in-obesity (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/chemotherapy-dosing-in-obesity/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "chemotherapy-dosing-in-obesity" ;
  schema:name "Full weight-based chemotherapy dosing for people with obesity"@en ;
  schema:alternateName "dose capping"@en, "chemotherapy dosing in obese patients"@en, "actual body weight dosing"@en, "ASCO obesity dosing guideline"@en ;
  schema:description "Chemotherapy doses used to be capped for larger people for fear of overdose. The American Society of Clinical Oncology guideline found that up to 40 per cent of people with obesity were given reduced doses, that the feared extra toxicity is unfounded, and recommends full doses based on actual body weight."@en ;
  schema:url <https://onco.cc/technologies/chemotherapy-dosing-in-obesity/> ;
  schema:dateModified "2026-10-20"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2011.39.9436>, <https://doi.org/10.1200/JCO.21.00471> ;
  onco:status "standard-of-care" ;
  onco:tag "precision", "evidence:moderate" ;
  onco:related <https://onco.cc/terms/obesity-related-cancers/> ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/body-surface-area-dosing/>, <https://onco.cc/technologies/ct-body-composition-sarcopenia/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:terms <https://onco.cc/terms/dose-modification/>, <https://onco.cc/terms/body-composition/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dose-optimisation/> .